UK markets open in 1 hour 43 minutes
NIKKEI 225
37,695.01 -765.07 (-1.99%) HANG SENG
17,249.60 +48.33 (+0.28%) CRUDE OIL
82.95 +0.14 (+0.17%) GOLD FUTURES
2,328.90 -9.50 (-0.41%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,466.62 -2,222.26 (-4.14%)
Allogene Therapeutics, Inc. (ALLO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.3700 |
| Open | 3.3700 |
| Bid | 3.0000 x 600 |
| Ask | 3.0700 x 400 |
| Day's range | 3.0300 - 3.4200 |
| 52-week range | 2.2300 - 6.8900 |
| Volume | |
| Avg. volume | 2,282,691 |
| Market cap | 518.998M |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
Allogene Therapeutics (ALLO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
How Allogene (ALLO) Stock Stands Out in a Strong Industry
Allogene (ALLO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- Simply Wall St.
We Think Allogene Therapeutics (NASDAQ:ALLO) Needs To Drive Business Growth Carefully
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
© 2024 Yahoo. All rights reserved.